Transformative Therapies for Autoimmune Diseases

Learn More

BioStock interview with CEO Kjell Stenberg

Read More

About Cyxone

Cyxone develops new innovative therapies for the treatment of rheumatoid arthritis and multiple sclerosis. Our goal is to improve the quality of life for patients in need of a more effective, convenient and safe treatment option.

Our Drug Projects

Rheumatoid Arthritis (rabeximod)

A unique mechanism-of-action combined with a convenient oral administration and a beneficial tolerability profile

Read More

Multiple sclerosis (T20K)

Acts to stop or slow down the progression of multiple sclerosis

Read More
Our mission is to provide better therapies for patients suffering from autoimmune diseases

Subscribe to Press Releases